Journal: Acta Cytologica
Submission Deadline: September 30, 2025
With this call for papers, Acta Cytologica welcomes submissions for an online article collection to explore the latest in disease-specific research and examinations into rare conditions.
The collection may cover original research and comprehensive reviews focused on HPV and gynaecological cytology and rare lesion studies as we aim to contribute to a deeper understanding of diagnostics and screening.
Submissions should aim to address gaps in knowledge and contribute to the future of cytological clinical practice and outcomes.
Topics may include:
- Use of HPV testing in the diagnosis of head- and neck cancer (HNSCC).
- Experiences on the use of p16 as a surrogate marker of HPV (at non-genital sites).
- Cervical cancer screening in the era of HPV vaccinations.
- Gynecological cytology, such as improved diagnosis of cervical glandular lesions or ovarian and fallopian tube diseases.
- Large multi-centre studies on rare lesions.
- Meta-analysis of single-case reports.
Please select the option “Call for Papers: Perspectives in Cytology, Disease, and Rare Conditions” when submitting your manuscript and mention this Call for Papers in your cover letter.
As a hybrid journal, Acta Cytologica supports Open Access publications. Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.
Check out the Author Guidelines.